High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States

Ophthalmology

Volumn 123, Issue 6, 2016, Pages 1257-1262

  Erie, Jay C ^a   Barkmeier, Andrew J ^a   Hodge, David O ^a   Mahr, Michael A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN INHIBITOR; ANGIOGENESIS INHIBITOR; HYBRID PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VEGFA PROTEIN, HUMAN;

AGED; ARTICLE; COHORT ANALYSIS; DRUG COST; GEOGRAPHIC DISTRIBUTION; HUMAN; MEDICAID; MEDICAL FEE; MEDICARE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; UNITED STATES; ANTAGONISTS AND INHIBITORS; CLINICAL PRACTICE; CURRENT PROCEDURAL TERMINOLOGY; ECONOMICS; FEMALE; GEOGRAPHY; HEALTH CARE COST; HEALTH SERVICES RESEARCH; INTRAVITREAL DRUG ADMINISTRATION; MALE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BEVACIZUMAB; COHORT STUDIES; CURRENT PROCEDURAL TERMINOLOGY; DRUG COSTS; FEE-FOR-SERVICE PLANS; FEMALE; GEOGRAPHY; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; INTRAVITREAL INJECTIONS; MALE; MEDICARE PART B; PRACTICE PATTERNS, PHYSICIANS'; RANIBIZUMAB; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; UNITED STATES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WET MACULAR DEGENERATION;

EID: 84960445723     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.02.015     Document Type: Article

References (29)

1. Comparison of Age-Related Macular Degeneration Treatment Trials (CATT) Research Group D.F. Martin, M.G. Maguire, and et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 2012 1388 1398
2. D.M. Brown, P.K. Kaiser, M. Michels, et al. for the ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
3. P.J. Rosenfeld, D.M. Brown, J.S. Heier, et al. for MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
4. BRAVO and CRUISE Trials Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion Ophthalmology 121 2014 1059 1066
5. The Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, and ranibizumab for diabetic macular edema N Engl J Med 372 2015 1193 1203
6. The CMS Blog. Medicare Drug Spending Dashboard. https://blog.cms.gov/2015/12/21/medicare-drug-spending-dashboard; Accessed March 6, 2016.
7. R.J. Brechner, P.J. Rosenfeld, J.D. Babish, and S. Caplan Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 Medicare fee-for-service part B claims file Am J Ophthalmol 151 2001 887 895
8. N.M. Holekamp, Y. Kiu, W. Yeh, and et al. Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration Am J Ophthalmol 157 2014 825 833
9. S. Kiss, Y. Liu, J. Brown, and et al. Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema Clin Ophthalmol 26 2014 1611 1621
10. Centers for Medicare and Medicaid Services Medicare Provider Utilization and Payment Data: Physician and Other Suppliers Available at http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Physician-and-Other-Supplier.html Accessed December 11, 2015
11. MedAssets CodeCorrect. Available at: http://www.codecorrect.com. Accessed December 15, 2015.
12. Medicare Advantage 2013 Spotlight: Enrollment Market Update. June 2013. Available at: http://kff.org/medicare/issue-brief/medicare-advantage-2013-spotlight-enrollment-market-update/. Accessed December 12, 2015.
13. B. Everitt The Cambridge Dictionary of Statistics 1998 Cambridge University Press New York
14. J. Appleby, V. Raleigh, and F. Frosini Variations in Health Care: The Good, the Bad, the Inexplicable 2011 King's Fund London
15. S.B. Bressler, B. Munoz, S.D. Solomon, S.K. West the Salisbury Eye Evaluation (SEE) Study Team Racial differences in the prevalence of age-related macular degeneration Arch Ophthalmol 126 2008 241 245
16. J.D. Birkmeyer, B.N. Reames, P. McCulloch, and et al. Understanding of regional variation in the use of surgery Lancet 382 2013 1121 1129
17. S. Keyhani, R. Falk, T. Bishop, and et al. The relationship between geographic variations and overuse of healthcare services: a systematic review Med Care 50 2012 257 261
18. B.N. Reames, S.P. Shubeck, and J.D. Birkmeyer Strategies for reducing regional variation in the use of surgery Ann Surg 259 2014 616 627
19. A.J. Schoenfeld, M.B. Harris, H. Liu, and J.D. Birkmeyer Variations in Medicare payments for episodes of spine surgery Spine J 14 2014 2793 2798
20. J.S. Heier, P.A. Campochiaro, L. Yau, and et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial Ophthalmology 119 2012 802 809
21. J.S. Heier, D.M. Brown, V. Chong, and et al. Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration Ophthalmology 119 2012 2537 2548
22. Y. Zhang, K. Baiker, and J.P. Newhouse Geographic variation in Medicare drug spending N Engl J Med 363 2010 405 409
23. W.L. Wong, X. Su, C.M. Cheung, and et al. Global prevalence of age-related macular degeneration and disease burden projections for 2020 and 2040: a systematic review and meta-analysis Lancet Glob Health 2 2014 e106 e116
24. E.H. Wagner, P. Barrett, M.J. Barry, and et al. The effect of shared decision making program on rates of surgery for benign prostatic hyperplasia. Pilot results Med Care 33 1995 765 770
25. M.I. Rob, J.I. Westbrook, R. Taylor, and et al. Increased rates of ENT surgery among young children: have clinical guidelines made a difference? J Paediatr Child Health 40 2004 627 632
26. J.C. Javitt, M. Kendix, D.M. Tielsch, and et al. Geographic variation in utilization of cataract surgery Med Care 33 1995 90 105
27. C.L. Goldzweig, B.S. Mittman, G.M. Carter, and et al. Variations in cataract extraction rates in Medicare prepaid and fee-for-service settings JAMA 277 1997 1765 1768
28. J.E. Wennberg, and F.J. Fowler A test of consumer contribution to small area variations in health care delivery J Maine Med Assoc 68 1977 275 279
29. The Dartmouth Institute of Health Policy and Clinical Practice. The Dartmouth Atlas of Healthcare 2013 Dartmouth Medical School Hanover, NH